Bridgeway Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Bridgeway Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-45,000	Closed	-$565K	–	1334
2020 Q3	$565K	Sell	45,000 -15,000	-25%	-$186K	0.01%	841
2020 Q2	$853K	Sell	60,000 -25,000	-29%	-$197K	0.02%	712
2020 Q1	$350K	Hold	85,000	–	–	0.01%	875
2019 Q4	$638K	Buy	85,000 +35,000	+70%	+$250K	0.01%	876
2019 Q3	$450K	Buy	+50,000	New	+$382K	0.01%	997

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridgeway Capital Management's IDYA Position: Q4 2020 in Review

Bridgeway Capital Management sold out of IDEAYA Biosciences (IDYA) in Q4 2020, closing a stake of 45,000 shares — an estimated $565K sold.

Bridgeway Capital Management first reported a position in IDYA in Q3 2019 and held it in 5 quarters. The position peaked at $853K in Q2 2020. 82 funds tracked by Wall St. Rank hold IDYA as of Q4 2020.

Bridgeway Capital Management reported no remaining IDEAYA Biosciences position as of Q4 2020 after selling out during the quarter.
Bridgeway Capital Management sold 45,000 IDEAYA Biosciences shares in Q4 2020, an estimated $565K.
Bridgeway Capital Management first reported a position in IDEAYA Biosciences in Q3 2019 and held it in 5 quarters.
Bridgeway Capital Management's IDEAYA Biosciences position peaked at $853K in Q2 2020.
82 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2020.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.